The treatment of<unk><unk>  (M.<unk>  skin and soft tissue infection includes draining collections of pus, surgical debridement, and administration of combination of antibiotics.  M.<unk>  has a variable in vitro drug susceptibilities profile; therefore, antibiotic susceptibility testing is required. The treatment of pulmonary M.<unk>  infection includes a combination of antibiotics and surgical resection of the localized disease.  M.<unk>  infection is treated by a macrolide-based multidrug antibiotic regimen.  The duration of the antibiotic regimen depends on the site of infection: 2-4 months in pulmonary infection, at least 4 months in skin and soft tissue infection, and 6 months for bone infection.
Mycobacterium abscessus medical therapy
Mucormycosis medical therapy
Paracoccidioidomycosis medical therapy
Aspergillosis medical therapy
Actinomycosis medical therapy
Zygomycosis medical therapy
Blastomycosis medical therapy
Histoplasmosis medical therapy